Estonia allocates €500,000 for companies joining European personalised medicine projects

Estonia’s Business and Innovation Agency (EIS) has announced €500,000 in national funding for Estonian companies participating in a new European Partnership for Personalised Medicine (EP PerMed) call.

The programme supports international research and product development in cell and gene therapies, including mRNA-based treatments. The overall European call has a budget of approximately €33 million.

Applications open on 4 November 2026, with preliminary proposals due by 20 January 2027. Eligible companies must participate in international consortia involving at least three independent partners from three countries. EIS funding is intended specifically for Estonian companies.

Source: EIS, 27 October 2026.